Adverse Event Clinical Research
1.0.1 - STU1 International flag

This page is part of the Adverse Event Clinical Research (v1.0.1: STU 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

MedicationRequest: medication-request-example-kadcyla1

Page standards status: Informative

Generated Narrative: MedicationRequest

Resource MedicationRequest "medication-request-example-kadcyla1"

status: active

intent: order

Medications

-Concept
*KADCYLA (RxNorm#1371046)

subject: Patient/patient-example-kaitlyn-b1 " HAMMER"

authoredOn: 2020-03-15

requester: Practitioner/practitioner-owen-oncologist " ONCOLOGIST"

dosageInstruction

text: Kadcyla IV at 3.6mg

timing: Starting 2020-04-03, Once

route: Intravenous route (qualifier value) (SNOMED CT#47625008)

doseAndRate

maxDosePerAdministration: 1